Hybrid drug-screening strategy identifies potential SARS-CoV-2 cell-entry inhibitors targeting human transmembrane serine protease

The spread of coronavirus infectious disease (COVID-19) is associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has risked public health more than any other infectious disease. Researchers around the globe use multiple approaches to identify an effective approved d...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yufei, Cheng, Xiaoning, Wu, Shuilong, Mani Saravanan, Konda, Liu, Wenxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091140/
https://www.ncbi.nlm.nih.gov/pubmed/35571866
http://dx.doi.org/10.1007/s11224-022-01960-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9091140/
https://www.ncbi.nlm.nih.gov/pubmed/35571866
http://dx.doi.org/10.1007/s11224-022-01960-w

Ejemplares similares